2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
45
Neoplasms
6
Colorectal Neoplasms
5
Neoplasm Metastasis
4
Adenocarcinoma
3
Resectable Pancreatic Cancer
2
Rectal Neoplasms
2
Pancreatic Cancer Metastatic
2
Carcinoma, Hepatocellular
2
Biliary Tract Neoplasms
2
Urachal cancer
1
Stomach Neoplasms
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Pancreatic Cancer Non-resectable
1
Pancreatic Adenocarcinoma
1
Neoplasms, Basal Cell
1
Locally Advanced Unresectable or Metastatic Solid Tumors
1
Locally Advanced Pancreatic Adenocarcinoma
1
Localized Pancreatic Adenocarcinoma
1
Gastrointestinal Neoplasms
1
Gastroesophageal Adenocarcinoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Pancreatic Ductal
1
Carcinoma, Islet Cell
1
Carcinoma
1
Borderline Resectable Pancreatic Cancer
1
Interventions
Gemcitabine
4
Leucovorin
2
Fluorouracil
2
tremelimumab
1
pamrevlumab
1
irinotecan sucrosofate
1
folfirinox
1
durvalumab
1
Taxes
1
Specimen Handling
1
Radiosurgery
1
Oxaliplatin
1
Medical Marijuana
1
Irinotecan
1
Heavy Ion Radiotherapy
1
Chemoradiotherapy
1
Capecitabine
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Pancreatic Cancer Non-resectable
×
folfirinox
×
Clear all
NCT03941093
2024-11-05
LAPIS
Kyntra Bio
Phase 3
Completed
284 enrolled
14 charts